Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:15 PM
Ignite Modification Date:
2025-12-24 @ 9:15 PM
NCT ID:
NCT03800004
Eligibility Criteria:
Inclusion Criteria:
* Children 5 to 17 years of age with a diagnosis of moderate to severe atopic dermatitis as made by a dermatologist
* Duration of atopic dermatitis symptoms for a minimum of 6 months
* Ability to cooperate with DXA and HR-pQCT procedure
Exclusion Criteria:
* Those without a confirmed diagnosis of moderate to severe atopic dermatitis
* Presence of concurrent disease that may also affect bone health, including rickets or other vitamin D deficiency, thyroid disease, renal disease, Paget's disease, osteogenesis imperfecta, inflammatory bowel disease, and other chronic inflammatory diseases
* Current use of medications that may affect bone health, including bisphosphonate, Forteo, Tymlos, denosumab, thiazide, heparin, medroxyprogesterone acetate, cyclosporine, and oral tacrolimus. However, medications that are used for atopic dermatitis treatment are allowed
* Pregnant or breast feeding females
* Inability to cooperate with the blood draw
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
5 Years
Maximum Age:
17 Years
Study:
NCT03800004
Study Brief:
Protocol Section:
NCT03800004